𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical implications of UGT1A1*28 genotype testing in colorectal cancer patients

✍ Scribed by Katerina Shulman; Ilana Cohen; Ofra Barnett-Griness; Abraham Kuten; Stephen B. Gruber; Flavio Lejbkowicz; Gad Rennert

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
184 KB
Volume
117
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

UGT1A1*28 polymorphism predicts irinotec
UGT1A1*28 polymorphism predicts irinotecan-induced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinoma
✍ Chun-Yu Liu; Po-Min Chen; Tzeon-Jye Chiou; Jin-Hwang Liu; Jen-Kou Lin; Tzu-Chen πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 159 KB

## Abstract ## BACKGROUND It is known that the uridine‐diphosphoglucuronosyl transferase 1A1 (UGT1A1)\*28 polymorphism reduces UGT1A1 enzyme activity, which may lead to severe toxicities in patients who receive irinotecan. This study was conducted to assess the influence of this polymorphism on th

Spectrum of UGT1A1 mutations in Crigler-
Spectrum of UGT1A1 mutations in Crigler-Najjar (CN) syndrome patients: identification of twelve novel alleles and genotype-phenotype correlation
✍ Veronica Servedio; Maria d'Apolito; Nunzia Maiorano; Barbara Minuti; Francesca T πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 137 KB

## Communicated by Sergio Ottolenghi Crigler-Najjar syndrome types I and II (CN1 and CN2) are usually inherited as autosomal recessive conditions and are characterized by non-hemolytic unconjugated hyperbilirubinaemia. CN1 is the most severe form, associated with the absence of hepatic bilirubin-u